SCHEMBL18794849

SCHEMBL18794849

NC(=O)C(F)(F)Oc1cc(Cl)cc(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC13A3 Q8WWT9 1/20 0.40
TLR8 Q9NR97 2/20 0.39
PPARG P37231 3/20 0.36
FFAR4 Q5NUL3 1/20 0.36
CES2 O00748 1/20 0.35
KIF11 P52732 1/20 0.35
GPR35 Q9HC97 2/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
TMPRSS4 Q9NRS4 1/20 0.34
RHOC P08134 3/20 0.34
RHOA P61586 3/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18814524 0.78 GPR35 (0.45) SLC13A3TLR8GPR35L3MBTL1
SCHEMBL18794840 0.76 PDK2 (0.46) SLC13A3TLR8FFAR4RHOCRHOA
SCHEMBL18814122 0.74 SCN9A (0.41) SLC13A3TLR8PPARGGPR35TMPRSS4
SCHEMBL18794823 0.74 SCN9A (0.41) SLC13A3TLR8PPARGGPR35TMPRSS4
SCHEMBL18794851 0.74 SCN9A (0.41) SLC13A3TLR8PPARGGPR35TMPRSS4
SCHEMBL23519056 0.72 CES2 (0.47) TLR8CES2GPR35LMNAMAPT
SCHEMBL18794845 0.71 PTGDR2 (0.50) SLC13A3FFAR4TDP1L3MBTL1
SCHEMBL2242247 0.70 CES2 (0.50) SLC13A3CES2HDAC3HDAC1HDAC2
SCHEMBL14054992 0.70 TMPRSS4 (0.46) SLC13A3TLR8GPR35HDAC3HDAC1
SCHEMBL14551849 0.69 TLR8 (0.37) SLC13A3TLR8PPARGFFAR4CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200181067-A1 FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS TRILLIUM THERAPEUTICS INC. (CA) 2020-06-11 US disclosed
US-20200181067-A1 FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS TRILLIUM THERAPEUTICS INC. (CA) 2020-06-11 US disclosed
US-10604476-B2 Fluorinated amide derivatives and their uses as therapeutic agents TRILLIUM THERAPEUTICS INC. (CA) 2020-03-31 US disclosed
US-20180334425-A1 FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS TRILLIUM THERAPEUTICS INC. (CA) 2018-11-22 US disclosed
EP-3368509-A1 FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS Trillium Therapeutics Inc. (CA) 2018-09-05 EP disclosed
WO-2017070795-A1 FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS TRILLIUM THERAPEUTICS INC. (CA) 2017-05-04 WO disclosed
WO-2017070795-A1 FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS TRILLIUM THERAPEUTICS INC. (CA) 2017-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180334425-A1 FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS GRIN2A, ACHE, BDNF SLC13A3 1803/4885TLR8 2175/4885PPARG 181/4885
US-10604476-B2 Fluorinated amide derivatives and their uses as therapeutic agents GRIN2A, ACHE, BDNF SLC13A3 1803/4885TLR8 2175/4885PPARG 181/4885
US-20200181067-A1 FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS GRIN2A, ACHE, BDNF SLC13A3 1803/4885TLR8 2175/4885PPARG 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.